Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith C Ferdinand

Showing results (91-100 of 287) with videos related to

Pageof 29
Sort By:
Mayo Clinic Proceedings|May 6, 2017
Disparate Cardiovascular Disease Rates in African Americans: The Role of Stress Related to Self-Reported Racial DiscriminationKeith C Ferdinand, Samar A Nasser
Current Medical Research and Opinion|March 17, 2015
Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitusKeith C Ferdinand, Samar A Nasser
JAMA Network Open|April 27, 2021
Will the 2021 USPSTF Hypertension Screening Recommendation Decrease or Worsen Racial/Ethnic Disparities in Blood Pressure Control?Keith C Ferdinand, Angela L Brown
Journal of the American College of Cardiology|April 25, 2020
African-American COVID-19 Mortality: A Sentinel EventKeith C Ferdinand, Samar A Nasser
Reviews in Cardiovascular Medicine|August 11, 2004
The epidemic of diabetes mellitus and the metabolic syndrome in African AmericansKeith C Ferdinand, Luther T Clark
Journal of the Cardiometabolic Syndrome|March 11, 2008
Noninvasive diagnosis of subclinical atherosclerosis in cardiometabolic syndrome: a call to actionCarol Kotliar, Pedro Forcada, Keith C Ferdinand
Current Medical Research and Opinion|November 16, 2017
Design of a 24-week trial of empagliflozin once daily in hypertensive black/African American patients with type 2 diabetes mellitusKeith C Ferdinand, Leo Seman, Afshin Salsali
Progress in Cardiovascular Diseases|January 11, 2020
The NEW-HOPE study and emerging therapies for difficult-to-control and resistant hypertensionKeith C Ferdinand, Daniel Harrison, Adedoyin Johnson
Annals of Translational Medicine|September 14, 2018
Hypertension and cardiovascular disease in the sub-Saharan African contextYackoob Seedat, Ayan Ali, Keith C Ferdinand
Circulation|May 3, 2021
Are SGLT2 Inhibitors New Hypertension Drugs?Kazuomi Kario, Keith C Ferdinand, Wanpen Vongpatanasin
Pageof 29

Showing results (91-100 of 287) with videos related to

Sort By:
Pageof 29
Mayo Clinic Proceedings|May 6, 2017
Disparate Cardiovascular Disease Rates in African Americans: The Role of Stress Related to Self-Reported Racial DiscriminationKeith C Ferdinand, Samar A Nasser
Current Medical Research and Opinion|March 17, 2015
Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitusKeith C Ferdinand, Samar A Nasser
JAMA Network Open|April 27, 2021
Will the 2021 USPSTF Hypertension Screening Recommendation Decrease or Worsen Racial/Ethnic Disparities in Blood Pressure Control?Keith C Ferdinand, Angela L Brown
Journal of the American College of Cardiology|April 25, 2020
African-American COVID-19 Mortality: A Sentinel EventKeith C Ferdinand, Samar A Nasser
Reviews in Cardiovascular Medicine|August 11, 2004
The epidemic of diabetes mellitus and the metabolic syndrome in African AmericansKeith C Ferdinand, Luther T Clark
Journal of the Cardiometabolic Syndrome|March 11, 2008
Noninvasive diagnosis of subclinical atherosclerosis in cardiometabolic syndrome: a call to actionCarol Kotliar, Pedro Forcada, Keith C Ferdinand
Current Medical Research and Opinion|November 16, 2017
Design of a 24-week trial of empagliflozin once daily in hypertensive black/African American patients with type 2 diabetes mellitusKeith C Ferdinand, Leo Seman, Afshin Salsali
Progress in Cardiovascular Diseases|January 11, 2020
The NEW-HOPE study and emerging therapies for difficult-to-control and resistant hypertensionKeith C Ferdinand, Daniel Harrison, Adedoyin Johnson
Annals of Translational Medicine|September 14, 2018
Hypertension and cardiovascular disease in the sub-Saharan African contextYackoob Seedat, Ayan Ali, Keith C Ferdinand
Circulation|May 3, 2021
Are SGLT2 Inhibitors New Hypertension Drugs?Kazuomi Kario, Keith C Ferdinand, Wanpen Vongpatanasin
Pageof 29